ReviewBMC pregnancy and childbirth2026
Severe rheumatic mitral stenosis and ARDS in pregnancy managed with percutaneous mitral commissurotomy and ECMO: a case report and literature review.
Review in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatic mitral stenosis (MS) remains a leading cause of cardiovascular complications in pregnancy, particularly in low-resource settings. Hemodynamic changes during pregnancy can precipitate decompensation in previously asymptomatic patients, increasing the risk of maternal and fetal morbidity. Early recognition and management, including percutaneous mitral commissurotomy (PMC) in selected cases, are crucial to optimizing outcomes. CASE PRESENTATION: We present the case of a 32-year-old pregnant woman (G4P3) at 22.6 weeks of gestation who developed severe respiratory distress and cardiogenic shock due to previously undiagnosed severe rheumatic MS. Initial management of respiratory distress at a rural hospital included inhaled beta-agonists; however, her condition rapidly deteriorated, requiring orotracheal intubation and urgent transfer to a tertiary care center. Transthoracic echocardiography confirmed severe MS (mitral valve area: 1.3 cm², mean gradient: 17 mmHg) with a severely dilated left atrium. A respiratory molecular panel was positive for Influenza A. Despite medical therapy, she developed refractory hypoxemia, distributive and cardiogenic shock, necessitating escalating vasopressor support and mechanical ventilation. A multidisciplinary team decision led to urgent PMC, successfully performed with a post-procedure mitral valve area of 2.6 cm². However, due to persistent respiratory failure, veno-venous extracorporeal membrane oxygenation (ECMO) was initiated, with successful decannulation after 33 days. The patient recovered without residual respiratory distress, and subsequent obstetric ultrasounds confirmed fetal viability and normal growth. She later underwent an uneventful delivery at 38 weeks, with favorable maternal and neonatal outcomes.
conclusionsThis case underscores the importance of early diagnosis, echocardiographic assessment, and multidisciplinary management in pregnant patients with severe MS. PMC remains the preferred intervention for severe symptomatic MS during pregnancy, significantly improving hemodynamics and reducing maternal risk. In cases of severe decompensation, ECMO serves as a life-saving bridge to recovery, ensuring both maternal stabilization and favorable perinatal outcomes. This case report highlights the need for preconception counseling, early intervention, and individualized care in high-risk pregnancies complicated by valvular heart disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.